1) Broeder AA, Creemers MC, Francen J, et al:Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor:A large retrospective study. J Rheumatol 34:689-695, 2007
2) Flynn JM, Rodrigues RF, Piza PA:Closed ankle fractures in the diabetic patients. Foot and Ankle Int 21:311-319, 2000
3) Giles JT, Bartlett SJ, Gelber AC, et al:Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum 55:333-337, 2006
4) 一山 智:感染症診療マスターブック.pp172-174,文光堂,東京,2007
5) Jevsevar DS, Karlin LI:The relationship between preoperative nutritional status and complications after an operation for scoliosis in patients who have cerebral palsy. J Bone Joint Surg Am 75:880-884, 1993
6) Latham R, Lancaster AD, Covington JF, et al:The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidermiol 22:607-612, 2001
7) Mangram AJ, Horan TC, Pearson ML, et al:Guideline for the prevention of surgical site infection. Infect Control Hosp Epidermiol 20:250-275, 1999
8) Scott JD, Forrest A, Feuerstein S, et al:Factors associated with postoperated infection. Infect Control Hosp Epidermiol 22:347-351, 2001
9) Shergy WJ, Phillips RM, Hunt RE, et al:Infliximab and its impact on surgical outcomes in patients with rheumatoid arthritis. Ann Rheum Dis 64 (Suppl III):465, 2005
10) Wendling D, Balblanc JC, Brousse A, et al:Surgery in patients receiving anti-tumor necrosis factor α treatment in rheumatoid arthritis:an observational study on 50 surgical procedures. Ann Rheum Dis 64:1378-1379, 2005